Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$11.43 USD
-0.25 (-2.14%)
Updated Aug 6, 2024 03:59 PM ET
After-Market: $11.43 0.00 (0.00%) 6:24 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -3.94 |
EPS Last Quarter | -2.28 |
Last EPS Surprise | -52.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -13.07 |
Next Year | 12.63 |
EPS (TTM) | -7.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 7.61M | 12.72M | 63.90M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.94 | -3.79 | -13.07 | 12.63 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -3.94 | -3.79 | -13.07 | 12.63 |
High Estimate | -3.94 | -3.79 | -13.07 | 12.63 |
Low Estimate | -3.94 | -3.79 | -13.07 | 12.63 |
Year ago EPS | -2.80 | -1.80 | -5.20 | -13.07 |
Year over Year Growth Est. | -40.71% | -110.56% | -151.35% | 196.63% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.94 | -3.79 | -13.07 | 12.63 |
7 Days Ago | -3.94 | -3.79 | -13.07 | 12.63 |
30 Days Ago | -3.94 | -3.79 | -13.07 | 12.63 |
60 Days Ago | -3.94 | -3.79 | -13.07 | 12.63 |
90 Days Ago | -3.94 | -3.79 | -13.07 | 12.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.94 | -3.79 | -13.07 | 12.63 |
Zacks Consensus Estimate | -3.94 | -3.79 | -13.07 | 12.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.28 | -0.80 | -1.80 | -2.80 | NA |
Estimate | -1.50 | NA | -2.80 | -1.60 | NA |
Difference | -0.78 | NA | 1.00 | -1.20 | -0.33 |
Surprise | -52.00% | NA | 35.71% | -75.00% | -30.43% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more